ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIR ALI M.D.

Pulmonary Disease

989

$164K

171
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 57%

$166
Average prescription price

Avg: $178

JOSEPH GOVERT M.D.

Pulmonary Disease

938

$141K

140
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

JOSE PEREZ MD

Pulmonary Disease

920

$263K

234
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$286
Average prescription price

Avg: $178

JAMES SNAPPER M.D.

Pulmonary Disease

894

$125K

126
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 57%

$140
Average prescription price

Avg: $178

KATHY MARKS M.D.

Pulmonary Disease

866

$136K

155
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 57%

$157
Average prescription price

Avg: $178

DAVID CLARK M.D.

Pulmonary Disease

860

$242K

184
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 57%

$281
Average prescription price

Avg: $178

HAKIM ALI MD

Pulmonary Disease

852

$169K

149
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 57%

$199
Average prescription price

Avg: $178

MURALI RAMASWAMY MD FAAFP

Pulmonary Disease

849

$225K

126
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 57%

$265
Average prescription price

Avg: $178

GUHAPRIYA PALANISWAMY MD

Pulmonary Disease

847

$142K

140
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 57%

$167
Average prescription price

Avg: $178

SCOTT LINDBLOM M.D.

Pulmonary Disease

828

$148K

108
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$179
Average prescription price

Avg: $178

BLAKE SPAIN MD

Pulmonary Disease

821

$120K

135
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 57%

$147
Average prescription price

Avg: $178

SHAW HENDERSON M.D.

Pulmonary Disease

816

$123K

115
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 57%

$151
Average prescription price

Avg: $178

WENDY MOORE MD

Pulmonary Disease

788

$107K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 57%

$136
Average prescription price

Avg: $178

PETER LOPER MD

Pulmonary Disease

785

$186K

91
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 57%

$237
Average prescription price

Avg: $178

DOUGLAS WHETSELL M.D.

Pulmonary Disease

781

$139K

72
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$178
Average prescription price

Avg: $178

ERIC MELTZER MD

Pulmonary Disease

771

$40.6K

68
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 57%

$53
Average prescription price

Avg: $178

TEREZA MARTINU M.D.

Pulmonary Disease

765

$176K

78
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 57%

$231
Average prescription price

Avg: $178

SAYEED HOSSAIN MD

Pulmonary Disease

764

$144K

140
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$188
Average prescription price

Avg: $178

RAHUL KAKKAR MD

Pulmonary Disease

725

$207K

140
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 57%

$285
Average prescription price

Avg: $178

JOHN CONFORTI DO

Pulmonary Disease

724

$138K

181
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 57%

$190
Average prescription price

Avg: $178

STUART ZEILENDER M.D.

Pulmonary Disease

721

$343K

123
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 57%

$476
Average prescription price

Avg: $178

ROBERT HEYER MD

Pulmonary Disease

721

$63.4K

46
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 57%

$88
Average prescription price

Avg: $178

RAKESH ALVA MD

Pulmonary Disease

698

$91.7K

137
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$131
Average prescription price

Avg: $178

WILLIAM HALL M.D.

Pulmonary Disease

697

$105K

130
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

GARY PRECHTER M.D.

Pulmonary Disease

693

$98.9K

138
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$143
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank